Skip to main content

ORIGINAL RESEARCH article

Front. Cardiovasc. Med.

Sec. Structural Interventional Cardiology

Volume 12 - 2025 | doi: 10.3389/fcvm.2025.1540595

This article is part of the Research Topic Insights in Structural Interventional Cardiology: 2023 View all 3 articles

Early and Mid-Term Outcomes of Transcatheter Closure of Perimembranous Ventricular Septal Defects Using Double-Disc Occluders

Provisionally accepted
Nguyen Cong Ha Nguyen Cong Ha *Nguyen Lan Viet Nguyen Lan Viet Nguyen Sinh Hien Nguyen Sinh Hien Nguyen Duc Hung Nguyen Duc Hung
  • Ha Noi Heart Hospital, Hanoi, Vietnam

The final, formatted version of the article will be published soon.

    Ventricular septal defect (VSD) is a common congenital heart disease (CHD), accounting for 20-30% of all CHD cases. While surgical closure has been the gold standard for treatment, transcatheter closure has emerged as a less invasive alternative, particularly for perimembranous VSDs. This study aimed to evaluate the early and mid-term outcomes of transcatheter closure using a double-disc occluder device in a single-center Vietnamese cohort. A prospective descriptive study was conducted at Hanoi Heart Hospital, Vietnam. A total of 81 patients aged ≥1 year or weighing ≥8 kg, with perimembranous VSDs and left-to-right shunting confirmed by Doppler echocardiography, underwent transcatheter closure. Procedural success, complications, and follow-up outcomes were assessed at 1, 3, 12, and 18 months post-procedure. Data were analyzed using SPSS 20.0. The procedure achieved a success rate of 96.4%, with three failures due to large defects near the aortic valve causing significant aortic regurgitation or residual shunting. No mortality or severe complications such as device embolization or complete atrioventricular block were observed. Minor complications included transient arrhythmias (6.2%), femoral hematoma (8.6%), and mild allergic reactions to contrast agents (9.9%). At 18 months follow-up, residual shunting was minimal in 1.2% of patients, and no cases required surgical intervention. Transcatheter closure of perimembranous VSD using a double-disc occluder device is a feasible, safe, and effective alternative to surgery with high success rates and low complication rates. This approach offers a promising solution for select patients, especially in resource-limited settings. Further multicenter studies are recommended to validate these findings and assess long-term outcomes. 1 Introduction Ventricular septal defect (VSD) is one of the most common congenital heart diseases 1,2 , accounting for approximately 20-30% of cases 3 . Over decades, various surgical and interventional approaches have been developed to manage VSD, including the traditional open-heart surgery with

    Keywords: Ventricular septal defect, Transcatheter closure, double-disc occluder, congenital heart disease, Procedural Outcomes

    Received: 06 Dec 2024; Accepted: 13 Mar 2025.

    Copyright: © 2025 Ha, Viet, Hien and Hung. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Nguyen Cong Ha, Ha Noi Heart Hospital, Hanoi, Vietnam

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more